MedTrace Logo

Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring Trials

NCT01618058 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2019-09-06

No results posted yet for this study

Summary

The purpose of this trial is to determine if exposure to ARV-containing investigational products in IPM clinical trials will impact the natural history of HIV infection as measured by the virologic, immunologic and clinical outcomes of participants who become HIV-positive during the IPM 027 trial.

Conditions

  • HIV Infections

Interventions

DRUG

No Investigational Product

This study is observational in nature and no investigational product will be used. Groups: ARV-Treated Participants, ARV-Naive Participants

Sponsors & Collaborators

  • International Partnership for Microbicides, Inc.

    lead INDUSTRY

Principal Investigators

  • Linda-Gail Bekker · Desmond Tutu HIV Centre

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-04
Primary Completion
2019-08-06
Completion
2019-08-06

Countries

  • Rwanda
  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01618058 on ClinicalTrials.gov